(2S,3R,4S,5S,6R)-2-(((2S,3R,4S,5S,6R)-4,5-二羟基-2-(((3R,6R)-2-羟基-6-((3S,8S,9R,10R,11R,13R,14S,17R)-11-羟基-4,4,9,13,14-五甲基-3-(((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-((((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)甲基)四氢-2H-吡喃-2-基)氧基)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊[a]菲-17-基)-2-甲基庚-3-基)氧基)-6-((((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-yl)氧基)甲基)四氢-2H-吡喃-3-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇; 罗汉果苷V; 罗汉果甜苷V; 罗汉果皂苷V
Mogroside V
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Mogroside V
CAS88901-36-4
FormulaC60H102O29
MW1,287.43
MDLMFCD00238649
Appearance White to off-white powder
Storage condition4°C, protect from light
Security information
Product details

Mogroside V, a key active component in Siraitiae Fructus, is a potent non-sugar sweetener with an in vitro AMPK-activating effect. It demonstrates anti-inflammatory properties in murine macrophages and a murine ear edema model, and it may protect against LPS-induced airway inflammation in acute lung injury (ALI) models. This triterpenoid glycoside also possesses antioxidant capabilities, mitigates intracellular reactive oxygen species (ROS) levels, and enhances mitochondrial function. Mogroside V exhibits anti-oxidative, anti-diabetic, and anti-carcinogenic effects, making it a valuable compound for diabetes research. It is particularly relevant for pancreatic cancer models, where it inhibits tumor growth.


Related
Sorry, no related items
History
Mogroside V
D-Pinitol; (1R,2S,3R,4S,5S,6S)-6-Methoxycyclohexane-1,2,3,4,5-pentaol
Deslanoside (Synonyms: Deacetyllanatoside C; Desacetyllanatoside C; 西地兰D,去乙酰西地兰,毛花洋地黄苷C,毛花强心丙)
Rediocide A
Rutaecarpine
Rosmarinic acid | Labiatenic acid
Lifastuzumab (Anti-SLC34A2)
Quassin | Nigakilactone D | (+)-Quassin
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Cadonilimab)
Labetalol Hydrochloride